Biocept Aktie [WKN DE: A2ASS5 / ISIN: US09072V2043]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Biocept Inc

21.08.18		LCI Whacked On Contract Loss, CWBR Awaits Data, Busy Months Ahead For PLSE (RTTNews)
12.07.18		EOLS Makes Investors Smile, ACIU Up 72% In 4 Days, Busy Days Ahead For ABUS (RTTNews)
18.06.18		Published Case Report Demonstrates the Clinical Utility of Biocept's CTC Platform in the Management of Patients with Metastatic Breast Cancer (PR Newswire)
11.06.18		VWR, Part of Avantor, and Biocept Announce the Launch of CEE-Sure Blood Collection Tubes for cfDNA and CTCs (PR Newswire)
29.05.18		Biocept to Present at the 8th Annual LD Micro Invitational Conference on June 5 (PR Newswire)
15.05.18		Biocept Reports First Quarter 2018 Financial Results (PR Newswire)
08.05.18		Biocept to Release First Quarter 2018 Financial Results and Host Investor Conference Call on May 15, 2018 (PR Newswire)
07.05.18		SenesTech, Inc. to Report First Quarter Fiscal Year 2018 Financial Results on Monday, May 14, 2018 (PR Newswire)
01.05.18		Case Report in Journal of Thoracic Oncology Demonstrates the Clinical Utility of Biocept's Liquid Biopsy Test for Patient Diagnosed with Non-Small Cell Lung Cancer (PR Newswire)
27.04.18		Published Case Study Demonstrates the Clinical Utility of Biocept's Liquid Biopsy Test for ALK Rearrangements (PR Newswire)
06.04.18		Biocept to Webcast Presentation at the 7th Annual MicroCap Conference (PR Newswire)
03.04.18		Biocept to Present at the 7th Annual MicroCap Conference (PR Newswire)
29.03.18		Biocept Obtains Patent for its Target Selector Molecular Biomarker Technology in China (PR Newswire)
28.03.18		Biocept Reports 2017 Fourth Quarter and Full Year Financial Results (PR Newswire)
28.03.18		Biocept and Thermo Fisher Scientific Enter into Technology and Commercial Collaboration (PR Newswire)
20.03.18		Biocept to Present Recent Advances in Biomarker Identification from Liquid Biopsies at GTCbio's 11th Biomarker Summit (PR Newswire)
15.03.18		Biocept's Target Selector Platform Featured in Two Poster Presentations at the 2018 American Association for Cancer Research Annual Meeting (PR Newswire)
12.03.18		Biocept to Release 2017 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 28, 2018 (PR Newswire)
06.03.18		Biocept to Present at the 30th Annual ROTH Conference (PR Newswire)
05.02.18		Biocept Receives Additional Patent Issuances in Three Major International Territories for its Target Selector Platform (PR Newswire)
30.01.18		Biocept Comments on Updated Consensus Medical Guidelines Recommending Liquid Biopsy for Profiling of Tumor Biomarkers to Assist with the Treatment of Patients with Lung Cancer (PR Newswire)
09.01.18		Biocept Study Shows Incorporation of Thermo Fisher QuantStudio 5 PCR Instrument into Target Selector Platform Improves Sensitivity and Specificity in Detection of Lung Cancer Biomarkers (PR Newswire)
04.01.18		Biocept Obtains Patent in Australia for its Molecular Biomarker Technology For the Detection of Cancer-Associated Mutations in Blood, Tissue, and Other Biological Sources (PR Newswire)
18.12.17		Biocept Signs In-Network Provider Agreement with Wellmark Blue Cross Blue Shield Expanding Coverage for its Target Selector Platform in Iowa and South Dakota (PR Newswire)
06.12.17		NVO Gets FDA Nod, GALT Down But Not Out, BIOC Gets A Boost, CUR Excited (RTTNews)
05.12.17		First U.S. Patent Issued for Biocept's Target Selector Oncogene Mutation Enrichment and Detection Liquid Biopsy ctDNA Platform (PR Newswire)
30.11.17		Edico Genome Launches DRAGEN Complete Suite On AWS Marketplace, Including Enhanced Second-Generation Germline And Somatic Pipelines (PR Newswire)
28.11.17		Biocept and UC San Diego Medical Center Announce Clinical Study Collaboration to Demonstrate Utility of Biocept's Liquid Biopsy Test in Immunotherapy (PR Newswire)
09.11.17		Biocept Reports Third Quarter 2017 Financial Results (PR Newswire)
02.11.17		Biocept to Release Third Quarter Financial Results and Host Investor Conference Call on November 9, 2017 (PR Newswire)
18.10.17		Biocept Launches Pathology Partnership Initiative Expanding Access of Proprietary Liquid Biopsy Testing to Community Pathologists and Hospitals (PR Newswire)
11.10.17		Renowned Lung Cancer Expert Fred R. Hirsch, M.D., Ph.D. Joins Biocept's Clinical Advisory Board (PR Newswire)
03.10.17		Biocept and Miraca Life Sciences Enter Into Marketing Agreement to Expand Target Selector Testing in the United States (PR Newswire)
05.09.17		Biocept Launches Liquid Biopsy Test for NRAS Mutations (PR Newswire)
28.08.17		Biocept to Present at the 6th Annual Gateway Conference on September 6, 2017 in San Francisco (PR Newswire)
17.08.17		Biocept and UT Southwestern Medical Center Announce Clinical Study to Profile and Monitor Non-Small Cell Lung Cancer Patients with ALK Rearrangements (PR Newswire)
14.08.17		Biocept Enters Into Exclusive Distribution Agreement with Global Laboratory Product Supplier VWR (PR Newswire)
11.08.17		Medical Laboratories Stocks on Investors' Radar -- DexCom, Novadaq Technologies, Biocept, and Exact Sciences (PR Newswire)
10.08.17		Biocept Reports Second Quarter 2017 Financial Results (PR Newswire)
10.08.17		Biocept Announces Private Placement of $2.2 Million of Common Stock with Ally Bridge LB Healthcare Master Fund (PR Newswire)
07.08.17		Biocept Executes Preferred Provider Agreement with Scripps Health Plan Expanding Patient Coverage for its Liquid Biopsy Platform (PR Newswire)
14.07.17		Biocept Expands Commercial Offering of Clinically Actionable Biomarker Assays with Launch of Liquid Biopsy Test for Progesterone Receptor Detection (PR Newswire)
26.06.17		Biocept Added to the Russell Microcap Index (PR Newswire)
21.06.17		Biocept and MediNcrease Health Plans Announce Provider Agreement Expanding Access to Liquid Biopsy Testing (PR Newswire)
24.05.17		Research Reports Coverage on Healthcare Stocks -- Biocept, Varian Medical Systems, Hill-Rom, and Tivity Health (PR Newswire)
22.05.17		Biocept Awarded U.S. Patent with Broad Claims for Antibody Capture of Targets of Interest on Any Solid Surface Including CTCs and Other Materials Shed by Solid Tumors into Blood (PR Newswire)
18.05.17		Biocept's Target Selector Platform Featured in Three Clinical Abstracts at the 2017 American Society of Clinical Oncology Annual Meeting Where Company Plans to Launch New Marketing Campaign (PR Newswire)
10.05.17		The Addario Lung Cancer Medical Institute and Biocept Announce Collaboration and Initiation of Landmark ALCMI-009 Liquid Biopsy Clinical Trial in Lung Cancer (PR Newswire)
10.05.17		Gainers & Losers Of May 9: VRX, ENDP, PTLA, SCYX, NXTM... (RTTNews)
09.05.17		Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range (PR Newswire)

1 | Weiter

Newssuche

Meistgelesene Nachrichten

Solana Kurs Prognose: Jetzt einsteigen und Millionär werden?

Pierer Mobility-Aktie mit zweistelligem Kurssprung: KTM AG wird fortgeführt - Eigenverwaltung bleibt

Crash oder Rally: Das sind die Experten-Prognosen für Kryptowährungen wie Bitcoin, Ethereum & Co. im Jahr 2025

Ripple bricht ein: Jetzt schnell verkaufen?

Krypto-Analyst klärt auf: Erhebliche Menge an Bitcoins geht jeden Tag verloren

Bitcoin kann Marke von 100.000 US-Dollar nicht bezwingen

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2024 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	29.12.2024 02:37
Kaufwert:	EUR
	Hinzufügen Speichern